Xevant Expands VerX Platform, Strengthening Its Role in the RxTech Era

As pressure grows across the healthcare industry to reduce prescription costs, healthcare analytics company Xevant has announced a significant expansion to its VerX™ Platform. VerX is Xevant’s core software solution, built to improve transparency and efficiency in pharmacy benefit management. This new suite of systems is designed to help clients simplify their drug pricing operations.

The Utah-based company said the recent advancements, named Cortex, Pulse, Axis, and Nudge, work together to automate cost optimization, streamline plan operations, and improve member engagement. These additions reinforce VerX’s role in what Xevant describes as the emerging “RxTech” segment, a technology-driven approach to pharmacy benefits designed to curb waste and lower net costs.

“When we launched VerX, we envisioned a platform for the next era of pharmacy benefits,” said Brandon Newman, CEO and Founder of Xevant. “Today, that vision is no longer theoretical. These interconnected systems—Cortex, Pulse, Axis, and Nudge—seamlessly and autonomously operate together to deliver real savings to every stakeholder in pharmacy.”

AI-Driven Systems Working in Tandem

The VerX platform’s expansion leverages the four coordinated systems to find savings and improve pharmacy plan results. They are designed to work together as a single, intelligent system for plan management.

Cortex, the “brain” of the operation, scans pharmacy claims, member history, and plan data to surface savings opportunities. At the same time, Pulse serves as the steady heartbeat that automates daily operations and tracks performance in real time. Axis then serves as the central nervous system, which helps route prescriptions along the most cost-effective path. Finally, Nudge is the reflex that prompts members to act so potential savings become tangible results.

Together, these four systems form what the company calls a “closed-loop flywheel of continuous intelligence.” Each insight feeds into measurable savings, and every member interaction contributes to improved outcomes across the pharmacy ecosystem.

Operationalizing RxTech

The announcement comes amid a broader shift in the healthcare landscape. Lawmakers and regulators are scrutinizing Pharmacy Benefit Managers (PBMs) for their pricing practices, while employers and insurers seek tools that offer greater visibility into drug costs.

Xevant’s VerX Platform aims to operationalize RxTech, a model that merges technology and pharmacy management to create direct, transparent pathways for cost optimization. The company stated the expanded platform operationalizes its cost management and member engagement functions through full automation. This marks the shift from strategic planning to a tangible, day-to-day management tool.

Moreover, recent developments in the industry, such as the TrumpRx–Pfizer agreement to enable direct purchasing at discounted prices, have underscored momentum toward rebate-free and transparent pricing models. Xevant’s VerX Platform supports this by integrating direct-to-patient and direct-to-provider solutions within a single system.

The platform delivers on these solutions in several specific ways. Through employer-funded GLP-1 carve-outs, Cortex-driven patient assistance programs that remove out-of-pocket costs, and real-time claim routing to the lowest-cost channels, the platform brings automation and data-driven intelligence to cost containment strategies that have traditionally required manual oversight.

Meeting Industry Demand for Transparency

“The industry is clearly at an inflection point,” said Nick Conway, President at Value Pharmacy Services. “Legacy models to manage a PBM can’t keep pace with the demand for transparency and real-time optimization. VerX brings the level of intelligence and automation needed to operate in the emerging PBM market, and it’s a glimpse of where pharmacy infrastructure is headed.”

The VerX Platform’s structure allows for continuous adaptation as pharmacy data and drug pricing evolve. Its AI systems automatically identify opportunities for savings, initiate actions, and validate results, a process Xevant says helps reduce the $250 billion in estimated annual prescription waste.

The company’s goal is to ensure that cost optimization becomes a built-in function of pharmacy benefits management rather than a separate initiative.

A Model for the Next Phase of Pharmacy Benefits

Xevant’s updates arrive as the pharmacy and health benefits sectors face mounting expectations for transparency and measurable outcomes. Policymakers are moving to regulate PBM pricing practices, while health plan sponsors and employers are demanding more insight into how their drug dollars are spent.

By combining cost containment, optimization, integration, and member engagement into one automated platform, Xevant positions VerX as a practical model for how AI can improve both financial and clinical results in pharmacy benefits.

The company said the interconnected systems within VerX, Cortex, Pulse, Axis, and Nudge, represent a foundation for RxTech: a pharmacy infrastructure that relies on real-time intelligence, direct access, and measurable performance rather than manual reconciliation or rebate-based incentives.

As the industry moves toward new standards for cost transparency and accountability, Xevant’s approach highlights the potential for technology to simplify pharmacy operations without disrupting care delivery. The company’s ongoing investment in automation and analytics reflects its view that the future of pharmacy benefits management will be defined by integration, data accuracy, and clear value measurement.